FeesSafety
Pluang+

Annovis Bio launches proposed public offering to fund Alzheimer’s and Parkinson’s drug development

Company Fundamentals
04 Nov 2026, 23:07 WIB
GlobeNewsWire
View Source
Neutral
Annovis Bio launches proposed public offering to fund Alzheimer’s and Parkinson’s drug development

Annovis Bio, a Phase 3 biotech company, announced a proposed public offering to sell common stock and warrants. The proceeds will support clinical development of its lead drug buntanetap for Alzheimer’s and Parkinson’s diseases, as well as general corporate needs. The offering is subject to market conditions and managed by Canaccord Genuity. This move aims to advance Annovis’s investigational oral therapy targeting neurodegenerative diseases.

Annovis Bio's proposed public offering provides context for health-sector stocks on Pluang as of Nov 05, 2026 04:11 WIB. Among 150 priced health-sector US stocks, 108 rose and 42 fell today. Moderna (MRNA) led with a price of USD 258.08 and a 1-day gain of +12.97%, contrasting with ADMA Biologics (ADMA) at USD 12.49 which saw 100% sell order activity despite a +12.42% price increase, while Bruker Corporation (BRKR) balanced buy and sell orders at USD 63.77 with a +12.87% rise.

More News

Chery unveils automotive-grade AI for robots and eVTOLs, advancing safe physical AI beyond vehicles.

Chery unveils automotive-grade AI for robots and eVTOLs, advancing safe physical AI beyond vehicles.

At the 2026 Chery International User Summit, Chery Auto showcased its new physical AI technology built on decades of automotive safety data and engineering. Their CheryMind AI model and CHERY All-World Engine support autonomous robots, robotaxis, and...

Market News
Bullish
56 minutes ago
NOVAGOLD shareholders approve deal to own 100% of Donlin Gold project in Alaska

NOVAGOLD shareholders approve deal to own 100% of Donlin Gold project in Alaska

NOVAGOLD shareholders approved a transaction for New NOVAGOLD to acquire the remaining 40% interest in the Donlin Gold project from Paulson Advisers, increasing NOVAGOLD's ownership from 60% to 100%. This consolidation makes New NOVAGOLD the ultimate...

Company Fundamentals
Bullish
1 hour ago
Fox Factory names Troy Henige as new Chief Technology Officer to boost innovation and product development.

Fox Factory names Troy Henige as new Chief Technology Officer to boost innovation and product development.

Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...

Company Fundamentals
Bullish
3 hours ago
3M agrees to $7.35B settlement for PFAS exposure claims affecting up to 120,000 people.

3M agrees to $7.35B settlement for PFAS exposure claims affecting up to 120,000 people.

3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...

Market News
Bearish
4 hours ago
Global e-learning market to reach $506.6B by 2032, growing 10.62% annually driven by corporate upskilling and digital access.

Global e-learning market to reach $506.6B by 2032, growing 10.62% annually driven by corporate upskilling and digital access.

The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App